World Journal of Experimental Medicine - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Rusman RD, Akil F, Parewangi ML, Daud NA, Bachtiar R, Kusuma SH, Rifai A. Gut microbiota and metabolic-associated steatosis liver disease: Unveiling mechanisms and opportunities for therapeutic intervention. World J Exp Med 2025; 15(4): 107316 [PMID: 41497693 DOI: 10.5493/wjem.v15.i4.107316]
URL:	https://www.wjgnet.com/2220-315X/full/v15/i4/107316.htm

(32) (33) (0) (0) (0) (7) (1) (1031) (8)

Number	Citing Articles
1	Xinyue Hu, Xiaofang Yang, Zhou Zhu, Zhihong Yang, Pengyu Wang, Min Wu, Ning Zhang. Dose–response relationships of normal blood lipid levels in metabolic and endocrine diseases: mechanistic similarities, differences, and functional insights. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1768784
2	Yeonsoo Kim, Seonghwan Hwang. Role of Sirtuin 6 in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease. Current Issues in Molecular Biology 2026; 48(5) doi: 10.3390/cimb48050435
3	Ruizhe Ren, Siying Ren, Yihan Xu, Xiao Liang, Xiyang Wei. Non-coding RNA networks in metabolic dysfunction-associated steatotic liver disease: Mechanisms and therapeutic perspectives. Liver Research 2026; 10(2) doi: 10.1016/j.livres.2026.05.002
4	Yanmei Yin, Yugang Li, Xiaobin Zhang, Mengwei Jia, Shu Zhu, Chengcheng Liu. Precision prebiotics: Engineering food-derived polysaccharides to target specific SCFA-producing taxa for neuroprotection via the microbiota-gut-brain axis. Current Research in Food Science 2026; 13 doi: 10.1016/j.crfs.2026.101471
5	Naomi-Adina Ciurea, Laura Mahdi, Annarita Graziani, Agostino Di Ciaula, Piero Portincasa, Mohamad Khalil. Targeting the Human Gut Microbiota—Between Conventional Therapy and Precision Genetic Engineering. Nutrients 2026; 18(12) doi: 10.3390/nu18121958
6	Christos Savvidis, Ioannis Ilias. Letter to the Editor: Circadian and microbial misalignment in metabolic dysfunction-associated steatotic liver disease - mechanistic insights and chronotherapeutic potential. World Journal of Experimental Medicine 2026; 16(2): 118228 doi: 10.5493/wjem.v16.i2.118228 Abstract(18) \| Core Tip(19) \| Full Article(HTML)(57) \| Full Article (PDF)-377K(8) \| Full Article with Cover (PDF)-563K(4) \| Full Article (XML)-73K(4) \| Audio-157K(3) \| Peer-Review Report-306K(8) \| Answering Reviewers-116K(9) \| Times Cited (0) \| Total Visits (84) \| Open
7	Akiko Syawalidhany Tahir, Amelia Rifai, Susanto Hendra Kusuma, Rini R Bachtiar, Nu'man A S Daud, Fardah Akil, Muhammad Luthfi Parewangi, Resha Dermawansyah Rusman. Carvedilol and nonselective-beta-blockers <i>vs</i> endoscopic ligation for prophylaxis of esophageal variceal hemorrhage in cirrhosis: Systematic review and meta-analysis. World Journal of Hepatology 2026; 18(5): 117049 doi: 10.4254/wjh.v18.i5.117049 Abstract(39) \| Core Tip(38) \| Full Article(HTML)(129) \| Full Article (PDF)-1233K(21) \| Full Article with Cover (PDF)-1479K(9) \| Full Article (XML)-137K(9) \| Audio-222K(1) \| Peer-Review Report-227K(14) \| Answering Reviewers-584K(18) \| Times Cited (0) \| Total Visits (242) \| Open
8	Kuo Fang, Ji Miao, Guobin Song. Insulin-like growth factor binding proteins in metabolic dysfunction-associated steatotic liver disease. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1853302

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.